Simplex Trading’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-220
| Closed | -$2.13M | – | 8394 |
|
|
2019
Q3 | $2.13M | Sell |
220
-263
| -54% | -$26.3K | 0.01% | 1293 |
|
|
2019
Q2 | $4.94M | Sell |
483
-269
| -36% | -$29K | 0.01% | 687 |
|
|
2019
Q1 | $8.56M | Buy |
752
+397
| +112% | +$29.2K | 0.02% | 441 |
|
|
2018
Q4 | $1.39M | Buy |
355
+44
| +14% | +$1.91K | ﹤0.01% | 1358 |
|
|
2018
Q3 | $1.7M | Buy |
311
+296
| +1,973% | +$20.2K | 0.01% | 1384 |
|
|
2018
Q2 | $124K | Sell |
15
-98
| -87% | -$7.56K | ﹤0.01% | 4044 |
|
|
2018
Q1 | $25K | Sell |
113
-310
| -73% | -$17.9K | ﹤0.01% | 3152 |
|
|
2017
Q4 | $535K | Buy |
423
+390
| +1,182% | +$28K | 0.02% | 682 |
|
|
2017
Q3 | $14K | Buy |
33
+20
| +154% | +$1.52K | ﹤0.01% | 3519 |
|
|
2017
Q2 | $6K | Buy |
13
+6
| +86% | +$335 | ﹤0.01% | 4509 |
|
|
2017
Q1 | $2K | Buy |
+7
| New | +$416 | ﹤0.01% | 5442 |
|
|
2016
Q4 | – | Sell |
-30
| Closed | -$9K | – | 6888 |
|
|
2016
Q3 | $9K | Sell |
30
-5
| -14% | -$288 | ﹤0.01% | 3747 |
|
|
2016
Q2 | $8K | Buy |
35
+32
| +1,067% | +$1.37K | ﹤0.01% | 3869 |
|
|
2016
Q1 | $5K | Sell |
3
-52
| -95% | -$1.64K | ﹤0.01% | 4168 |
|
|
2015
Q4 | $47K | Sell |
55
-312
| -85% | -$16.4K | ﹤0.01% | 1968 |
|
|
2015
Q3 | $140K | Buy |
367
+263
| +253% | +$13.7K | 0.01% | 1148 |
|
|
2015
Q2 | $45K | Buy |
104
+84
| +420% | +$5.55K | ﹤0.01% | 1782 |
|
|
2015
Q1 | $2K | Buy |
+20
| New | +$1.15K | ﹤0.01% | 4264 |
|
Simplex Trading's ONCE Position: Q3 2019 in Review
Simplex Trading sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q3 2019, closing a stake of 221 shares — an estimated $22.1K sold.
Simplex Trading first reported a position in ONCE in Q4 2015 and held it in 11 quarters. The position peaked at $4.93M in Q1 2019. 184 funds tracked by Wall St. Rank hold ONCE as of Q3 2019.
- Simplex Trading reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
- Simplex Trading sold 221 Spark Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $22.1K.
- Simplex Trading first reported a position in Spark Therapeutics, Inc. Common Stock in Q4 2015 and held it in 11 quarters.
- Simplex Trading's Spark Therapeutics, Inc. Common Stock position peaked at $4.93M in Q1 2019.
- 184 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q3 2019.
Based on Simplex Trading's 13F filing for Q3 2019, filed 15 Oct 2019.